Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428851 (US10532048, Example 236) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428855 (US10532048, Example 631) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428852 (US10532048, Example 542) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428853 (US10532048, Example 560) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428854 (US10532048, Example 589) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428856 (US10532048, Example 700) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428859 (US10532048, Example 712) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428860 (US10532048, Example 856) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 6.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428857 (US10532048, Example 701) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 7.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428858 (US10532048, Example 709) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428841 (US10532048, Example 61) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bombesin receptor subtype-3 (Homo sapiens (Human)) | BDBM428850 (US10532048, Example 62) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Seldar Pharma Inc. US Patent | Assay Description A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur... | US Patent US10532048 (2020) BindingDB Entry DOI: 10.7270/Q22R3V1R | |||||||||||
More data for this Ligand-Target Pair |